Nantahala Capital Management, LLC

Holdings History for UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY)

Symbol: UNCY on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 1,855,991 shares
Security Ownership %: 10%

Shares, Excluding Options vs Price

Value, Excluding Options

Nantahala Capital Management, LLC ownership in UNICYCIVE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (UNCY)

14 Nov 2025 - Nantahala Capital Management, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,855,991 shares of UNICYCIVE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (UNCY). This represents 10% ownership of the company. In their previous filing dated 14 Aug 2025, Nantahala Capital Management, LLC had reported owning 1,234,596 shares, indicating an increase of +50%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Nantahala Capital Management, LLC	10%	0%	$1,391,993	1,855,991	+621,395	+50%	$0.75	13G/A	30 Sep 2025	14 Nov 2025, 16:36
Nantahala Capital Management, LLC	10%	0%	$925,947	1,234,596	-11,008,790	-90%	$0.75	13G/A	30 Jun 2025	14 Aug 2025, 16:38
Nantahala Capital Management, LLC	10%	0%	$7,713,333	12,243,386	+1,364,244	+13%	$0.63	13G/A	31 Mar 2025	15 May 2025, 16:39
Nantahala Capital Management, LLC	10%	0%	$6,853,859	10,879,142	+719,793	+7.1%	$0.63	13G/A	19 Dec 2024	20 Dec 2024, 16:32
Nantahala Capital Management, LLC	10%		$6,400,390	10,159,349			$0.63	13G/A	30 Sep 2024	14 Nov 2024, 16:53

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2025		-0.45%	$0	0	-9,391,994	-100%	$0.75	Q2 2025
31 Mar 2025	0.45%	-0.05%	$5,399,457	9,391,994	-1,000,000		$0.57	Q1 2025
31 Dec 2024	0.58%	+0.42%	$8,253,321	10,391,994	+7,571,636	+268%	$0.79	Q4 2024
30 Sep 2024	0.1%	0%	$1,150,424	2,820,358	0		$0.41	Q3 2024
30 Jun 2024	0.14%	0%	$1,413,282	2,820,358	0		$0.50	Q2 2024
31 Mar 2024		0%	$8,644,198	3,335,586	0		$2.59 ^*	Q1 2024
31 Dec 2023	0.3%	-0%	$2,983,309	3,438,181	-32,360	-0.93%	$0.87	Q4 2023
30 Sep 2023	0.38%	+0.31%	$2,984,666	3,470,541	+2,823,125	+436%	$0.86	Q3 2023
30 Jun 2023	0.1%	0%	$828,692	647,416	0		$1.28	Q2 2023
31 Mar 2023	0.13%	0%	$1,359,574	647,416	0		$2.10	Q1 2023
31 Dec 2022	0.03%	-0%	$349,605	647,416	-63,126	-8.9%	$0.54	Q4 2022
30 Sep 2022	0.04%	-0%	$419,000	710,542	-19,138	-2.6%	$0.59	Q3 2022
30 Jun 2022	0.05%	+0.01%	$606,000	729,680	+89,047	+14%	$0.83	Q2 2022
31 Mar 2022	0.06%	-0%	$826,000	640,633	-46,123	-6.7%	$1.29	Q1 2022
31 Dec 2021	0.09%	-0%	$1,415,000	686,756	-13,244	-1.9%	$2.06	Q4 2021
30 Sep 2021	0.12%	+0.12%	$1,981,000	700,000	+700,000	NEW	$2.83	Q3 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.